HIDEO SIGEMATSU

Last Updated :2024/05/15

Affiliations, Positions
Research Institute for Radiation Biology and Medicine, Associate Professor or Lecturer
E-mail
shigematu1330hiroshima-u.ac.jp
Self-introduction
I work as a breast oncologist. My research theme is omisson of surgery for breast cancer patients showing clinical complete response to primary systemic therapy.

Basic Information

Academic Degrees

  • Hiroshima University

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical surgery;General surgery

Educational Activity

Course in Charge

  1. 2024, Graduate Education (Doctoral Program) , 1Term, Practice of Oncology

Research Activities

Academic Papers

  1. Long-Term Outcomes of a Randomized Study of Neoadjuvant Induction Dual HER2 Blockade with Trastuzumab and Lapatinib Followed by Weekly Paclitaxel Plus Dual HER2 Blockade for HER2-Positive Primary Breast Cancer (Neo-Lath Study)., Cancers, 20210809
  2. Omitting surgery for early breast cancer showing clinical complete response to primary systemic therapy, Jpn J Clin Oncol, 20200610
  3. Cryotherapy for the prevention of weekly paclitaxel-induced peripheral adverse events in breast cancer patients, Support Care Cancer, 20201028
  4. Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer, World J Surg Oncol, 20190223
  5. Effect of denosumab on low bone mineral density in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: 24-month results, Breast Cancer, 20180727
  6. Overexpression of topoisomerase II alpha protein is a factor for poor prognosis in patients with luminal B breast cancer, Oncotarget, 20180101
  7. Comparison of CK-IHC assay on serial frozen sections, the OSNA assay, and in combination for intraoperative evaluation of SLN metastases in breast cancer., Breast Cancer, 20171101
  8. Role of 18F-PET/CT in Predicting Prognosis of Patients With Breast Cancer After Neoadjuvant Chemotherapy., Clin Breast Cancer, 20170919
  9. A case report of locally advanced triple negative breast cancer showing pathological complete response to weekly paclitaxel with bevacizumab treatment following disease progression during anthracycline-based neoadjuvant chemotherapy., Int J Surg Case Rep, 293-296, 20170901
  10. Neutrophil elastase induces cell proliferation and migration by the release of TGF-alpha, PDGF and VEGF in esophageal cell lines, Oncol Rep, 17(1), 161-7, 20070101
  11. Significant survival improvement of patients with recurrent breast cancer in the periods 2001-2008 vs. 1992-2000, BMC CANCER, 11, 20110331
    Link to Paper Search Results by DOI
  12. A case of HER-2-positive recurrent breast cancer showing a clinically complete response to trastuzumab-containing chemotherapy after primary treatment of triple-negative breast cancer, WORLD JOURNAL OF SURGICAL ONCOLOGY, 9, 20111107
    Link to Paper Search Results by DOI
  13. Technical Feasibility and Cosmetic Advantage of Hybrid Endoscopy-Assisted Breast-Conserving Surgery for Breast Cancer Patients, JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES, 23(2), 91-99, 201302
    Link to Paper Search Results by DOI
  14. Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer - Usefulness for malignant grade of triple-negative breast cancer, BREAST, 22(5), 958-963, 201310
    Link to Paper Search Results by DOI
  15. Three models for predicting the risk of non-sentinel lymph node metastasis in Japanese breast cancer patients, BREAST CANCER, 21(5), 571-575, 201409
    Link to Paper Search Results by DOI
  16. Role of FDG-PET/CT in Prediction of Underestimation of Invasive Breast Cancer in Cases of Ductal Carcinoma In Situ Diagnosed at Needle Biopsy, CLINICAL BREAST CANCER, 14(5), 358-364, 201410
    Link to Paper Search Results by DOI
  17. Utility of F-18 FDG-PET/CT for predicting prognosis of luminal-type breast cancer, BREAST CANCER RESEARCH AND TREATMENT, 150(1), 209-217, 201502
    Link to Paper Search Results by DOI
  18. The Efficacy and Safety of Preoperative Chemotherapy With Triweekly Abraxane and Cyclophosphamide Followed by 5-Fluorouracil, Epirubicin, and Cyclophosphamide Therapy for Resectable Breast Cancer: A Multicenter Clinical Trial, CLINICAL BREAST CANCER, 15(2), 110-116, 201504
    Link to Paper Search Results by DOI
  19. Clinical Significance of Extracapsular Invasion at Sentinel Lymph Nodes in Breast Cancer Patients with Sentinel Lymph Node Involvement, ANNALS OF SURGICAL ONCOLOGY, 22(7), 2365-2371, 201507
    Link to Paper Search Results by DOI
  20. EVALUATION OF MALIGNANCY GRADE OF BREAST CANCER USING PERFLUBUTANE-ENHANCED ULTRASONOGRAPHY, ULTRASOUND IN MEDICINE AND BIOLOGY, 42(5), 1049-1057, 201605
    Link to Paper Search Results by DOI
  21. Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 46(4), 303-309, 201604
    Link to Paper Search Results by DOI